Results 101 to 110 of about 498 (114)

Long‐Acting Lipoglycopeptides Can Interfere With Vancomycin Therapeutic Drug Monitoring

Journal of Clinical Pharmacology, 2022
Erin K Mccreary, Warren E Rose
exaly  

New Lipoglycopeptides

Drugs, 2012
George G Zhanel, Frank Schweizer, Sheryl A Zelenitsky   +2 more
exaly  

Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review

Pharmacotherapy, 2020
Martin Krsak, Taylor Morrisette, matthew miller   +2 more
exaly  

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections

Expert Review of Anti-Infective Therapy, 2008
George G Zhanel, Philippe R Lagacé-Wiens   +1 more
exaly  

Biotransformations of Lipoglycopeptides to Obtain Novel Antibiotics

Journal of Antibiotics, 2007
Raffaella Gandolfi, Flavia Marinelli, Francesco Molinari   +2 more
exaly  

231. Retrospective Comparison of Intravenous Therapy, Oral Therapy, and Lipoglycopeptides for the Treatment of Osteomyelitis

Open Forum Infectious Diseases, 2021
exaly  

Beyond Vancomycin: The Tail of the Lipoglycopeptides

Clinical Therapeutics, 2015
Kenneth P Klinker
exaly  

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs

Open Forum Infectious Diseases, 2019
Taylor Morrisette, R Brett Mcqueen, Martin Krsak   +2 more
exaly  

Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity

Science Translational Medicine
Emma van Groesen, Elma Mons, Melina Arts
exaly  

Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I

Journal of Biological Chemistry, 2004
exaly